Estimates Revisions Spero Therapeutics, Inc. Börse Stuttgart
Stocks
2HA
US84833T1034
Biotechnology & Medical Research
|
Delayed
Börse Stuttgart
01:16:21 11/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 0.9860 EUR | -1.50% |
|
-4.30% | -47.48% |
| 13/08 | Spero Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 13/08 | Spero Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Spero Therapeutics, Inc.(SPRO)
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Earnings Per Share (EPS)
Data source:
Spero Therapeutics, Inc.(SPRO)
- Stock Market
- Stocks
- SPRO Stock
- 2HA Stock
- Consensus Spero Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
